Terra Drone Corporation, recognized as the No.1 Drone Service Provider in the world for 2024, has announced the simultaneous release of its in-house developed indoor inspection drone, “TerraXross 1”, in Japan and the United States. Featuring advanced technologies, “Terra Xross 1” ensures stable flight performance, even in challenging indoor conditions, with affordable initial costs. https://mma.prnewswire.com/media/2608674/Terra_Xross1_KV.jpg […]

(NASDAQ:NXT), NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Nextracker Inc. (NASDAQ: NXT) between February 1, 2024 and August 1, 2024, both dates inclusive (the “Class Period”), of the important February 25, 2025 lead plaintiff deadline. SO WHAT: If

NASA will host a media teleconference at 1 p.m. EST Friday,Feb. 7, to discuss the agency's science and technology flying aboard Intuitive Machines' second flight to the Moon. The mission is part of NASA's CLPS (Commercial Lunar Payload Services) initiative and Artemis campaign to establish a long-term lunar presence. https://mma.prnewswire.com/media/2610811/image001.jpg Audio of the call will

(NasdaqGM:BBNX), IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the closing of its upsized initial public offering of 13,800,000 shares of common stock, including the full exercise of the underwriters' option to purchase 1,800,000 additional shares, consisting

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Unisys Corporation (NYSE: UIS) resulting from allegations that Unisys may have issued materially misleading business information to the investing public. So What: If you purchased Unisys securities you may be entitled to

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg So what: If you purchased Regeneron securities during the Class Period you

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to the registration statement for BioAge's initial public offering conducted on September 26, 2024 (the “IPO”), of the important March 10, 2025 lead plaintiff deadline. So what: If you purchased BioAge stock

NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=126444&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Report with market evolution powered by AI – The global smart healthcare marketsize is estimated to grow by USD 125.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 9.31% during the forecast period. Growing demand for remote health monitoringis driving market growth,with a trend towardsiot in healthcare.

(NASDAQ:MGPI), NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients, Inc. (NASDAQ: MGPI) between May 4, 2023 and October 30, 2024 (the “Class Period”), of the important February 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased